Steven Lyman Wood
Burglar Alarm in Orem, UT

License number
Utah 6955449-6502
Category
Burglar Alarm
Type
Burglar Alarm Company Agent
Address
Address
Orem, UT

Personal information

See more information about Steven Lyman Wood at radaris.com
Name
Address
Phone
Steven Wood, age 57
5219 S Ridgeline Dr, Ogden, UT 84405
Steven Wood, age 45
5016 W Silvertip Dr, Salt Lake Cty, UT 84118
(801) 558-8610

Professional information

Steven Wood Photo 1

Pharmaceutical Compositions Having Antiviral Activity Against Human Cytomegalovirus

US Patent:
6686393, Feb 3, 2004
Filed:
Sep 16, 1992
Appl. No.:
07/946813
Inventors:
Bronwyn G. Hughes - Orem UT
Steven G. Wood - Orem UT
Assignee:
Murdock International Corporation - Springville UT
International Classification:
A61K 31195
US Classification:
514561, 514680
Abstract:
The present invention is directed to the use of antiviral compounds having the following generalized structure: wherein R is 2H or O; R′ is OH, H, or COOH (single substitution); and R″ is OH, H, or alkyl; and pharmaceutically acceptable salts thereof as therapeutic substances having antiviral activity against human cytomegalovirus (“HCMV”) and for treating diseases caused by HCMV. Dimeric forms of the forgoing antiviral compounds having antiviral activity against HCMV are also disclosed. Pharmaceutical compositions containing the disclosed antiviral compounds are disclosed for topical and systemic administration.


Steven Wood Photo 2

Antihypertensive Compound From Caesalpinia Brasiliensis

US Patent:
6569891, May 27, 2003
Filed:
May 2, 2002
Appl. No.:
09/979376
Inventors:
Noel L. Owen - Provo UT
Steven Glen Wood - Orem UT
Assignee:
Brigham Young University - Provo UT
International Classification:
A61K 31352
US Classification:
514453, 549381, 536 41, 514 25
Abstract:
A compound isolated from an aqueous leachate of heartwood of “Palo de Brazil” has antihypertensive activity. The compound was isolated by reversed-phase high pressure liquid chromatography to separate it from haematoxylin, which is co-extracted with the new compound. The compound is effective in reducing the blood pressure of hypertensive Sprague-Dawley rats.


Steven Wood Photo 3

Sulfur-Substituted Diphenyl Ethers Having Antiviral Activity

US Patent:
4505929, Mar 19, 1985
Filed:
Aug 16, 1982
Appl. No.:
6/408362
Inventors:
Lowell D. Markley - Midland MI
Yulan C. Tong - Walnut Creek CA
Steven G. Wood - Orem UT
Assignee:
The Dow Chemical Company - Midland MI
International Classification:
A01N 3734, C07C12150, C07C14378, C07C14374
US Classification:
514520
Abstract:
Novel compounds exhibiting antiviral activity are disclosed, such compounds are represented by the formula: ##STR1## wherein m represents the integer 0, 1 or 2; R represents trihalomethyl, alkyl or phenyl; R. sub. 1 represents hydrogen, bromo, chloro, fluoro, cyano, nitro, amino, alkyl, alkoxy or trifluoromethyl; R. sub. 2 represents hydroxyl, bromo, chloro, fluoro, cyano, acetyl, benzoyl, substituted benzoyl, alkyl, alkoxy, substituted alkoxy, benzyl, substituted benzyl, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, or the radical --O(CH. sub. 2). sub. n R. sub. 4 wherein n represents the integer 1, 2 or 3 and R. sub. 4 represents cyano or dialkylamino; R. sub. 3 represents hydrogen, hydroxyl, bromo, chloro, fluoro, cyano, acetyl, benzoyl, substituted benzoyl, alkyl, alkoxy, substituted alkoxy, benzyl, substituted benzyl, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, or the radical --O(CH. sub. 2). sub. n R. sub. 4 wherein n represents the integer 1, 2 or 3; and R. sub.


Steven Wood Photo 4

Dispenser For Medicaments In Meltable Formulations

US Patent:
4865480, Sep 12, 1989
Filed:
Jul 20, 1987
Appl. No.:
7/075523
Inventors:
Valdon G. Reynolds - Bountiful UT
Steven M. Wood - Orem UT
Joseph T. Sorenson - Salt Lake City UT
Assignee:
Sorenson Development Incorporated - Salt Lake City UT
International Classification:
B43K 2108, A61M 3500
US Classification:
401175
Abstract:
An applicator for dispensing metered amounts of medicaments in stick formulations is comprised of a hollow tube and a piston mounted to slidingly move within the tube. A finger operable base is rotatably mounted at one end of the tube and is mechanically linked by a screw member to the piston to urge the piston towards the other end of the tube. A depressible thumb piece is associated with the rotatable base. An extension or post is associated with the thumb piece to extend inward of the tube and to register with a race formed inside the tube. The race has a series of detents with which the extension may register upon rotation of the base. Registration between the extension and the detents signals certain increments of rotation or prevents further rotation of the base. The thumb piece is depressed inward to bring the extension out of registration with the detents. A medicated formulation is disposed within the tube such that the piston urges the formulation towards the other end of the tube to extend an incremental amount of the formulation beyond the open end of the tube to be applied directly to the user.


Steven Wood Photo 5

Sulfur-Substituted Diphenyl Ethers Having Antiviral Activity

US Patent:
4349568, Sep 14, 1982
Filed:
Jun 12, 1980
Appl. No.:
6/158964
Inventors:
Lowell D. Markley - Midland MI
Yulan C. Tong - Walnut Creek CA
Steven G. Wood - Orem UT
Assignee:
The Dow Chemical Company - Midland MI
International Classification:
A61K 31135, A61K 3110, C07C 43263
US Classification:
424330
Abstract:
Novel compounds exhibiting antiviral activity are disclosed, such compounds are represented by the formula: ##STR1## wherein m represents the integer 0, 1 or 2; R represents trihalomethyl, alkyl or phenyl; R. sub. 1 represents hydrogen, bromo, chloro, fluoro, cyano, nitro, amino, alkyl, alkoxy or trifluoromethyl; R. sub. 2 represents hydroxyl, bromo, chloro, fluoro, cyano, acetyl, benzoyl, substituted benzoyl, alkyl, alkoxy, substituted alkoxy, benzyl, substituted benzyl, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, or the radical --O(CH. sub. 2). sub. n R. sub. 4 wherein n represents the integer 1, 2 or 3 and R. sub. 4 represents cyano or dialkylamino; R. sub. 3 represents hydrogen, hydroxyl, bromo, chloro, fluoro, cyano, acetyl, benzoyl, substituted benzoyl, alkyl, alkoxy, substituted alkoxy, benzyl, substituted benzyl, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, or the radical --O(CH. sub. 2). sub. n R. sub. 4 wherein n represents the integer 1, 2 or 3; and R. sub.


Steven Wood Photo 6

Lipopolysaccharide Isolated From Pyrularia Tissue And/Or Pyrularia-Associated Bacteria And Uses Thereof

US Patent:
2011007, Mar 24, 2011
Filed:
Sep 24, 2010
Appl. No.:
12/890502
Inventors:
STEVEN G. WOOD - OREM UT, US
KATIE SOUTHWICK - AVENEL NJ, US
L. DEE NORD - OREM UT, US
International Classification:
A61K 39/00, C07H 15/06, A61K 31/739, A61K 38/19, A61P 35/00
US Classification:
4242771, 536 182, 514 25, 514 11
Abstract:
This disclosure provides, in certain embodiments, methods for generating and using extracts of (e.g., ) and/or epiphytic/endophytic bacteria associated therewith, either alone or in combination with conventional immunostimulant(s) or anti-inflammatory agents, for modulation of the immune system of a subject. Also provided are compositions that include specific extracts, bacteria isolated from tissue (in particular, species), and extracts of from such bacteria. Also provided herein are purified components of extracts and/or extracts from the epiphytic/endophytic bacteria, which extracts exhibit mitogenic or cytotoxic activities. Compositions provided herein can be used for the treatment of neutropenia subsequent to chemotherapy, and for the treatment of immune deficiency (e.g., such as is caused by toxic chemotherapy, disease, or advancing age), as well as in other immune-stimulatory methods. Other embodiments of the invention provide methods of producing extracts of the invention, as well as purified bioactive components thereof, including particularly bacterial LPS.


Steven Wood Photo 7

2,5-Bis Alkyl Sulfonyl And 2,5-Bis Alkyl Thio Substituted-Pyridines

US Patent:
4616087, Oct 7, 1986
Filed:
May 21, 1982
Appl. No.:
6/380642
Inventors:
Steven G. Wood - Orem UT
Assignee:
The Dow Chemical Company - Midland MI
International Classification:
C07D21172, C07D21184
US Classification:
546294
Abstract:
A process for preparing substituted-pyridines having a sulfonyl type substituted at the 3 or 5 position of the pyridine ring and a phenoxy type substituent at the 2 position is described.


Steven Wood Photo 8

Pharmaceutical Compositions Having Antiviral Activity Against Human Cytomegalovirus

US Patent:
5316768, May 31, 1994
Filed:
Sep 11, 1992
Appl. No.:
7/943748
Inventors:
Bronwyn G. Hughes - Orem UT
Steven G. Wood - Orem UT
Assignee:
Murdock International Corporation - Springville UT
International Classification:
A61K 3578
US Classification:
424433
Abstract:
The present invention is directed to the use of antiviral compounds having the following generalized structure: ##STR1## wherein R is 2H or. dbd. O; R' is OH, H, or COOH (single substitution); and R" is OH, H, or alkyl; and pharmaceutically acceptable salts thereof as therapeutic substances having antiviral activity against human cytomegalovirus ("HCMV") and for treating diseases caused by HCMV. Dimeric forms of the forgoing antiviral compounds having antiviral activity against HCMV are also disclosed. Pharmaceutical compositions containing the disclosed antiviral compounds are disclosed for topical and systemic administration.


Steven Wood Photo 9

Sulfur-Substituted Phenoxypyridines Having Antiviral Activity

US Patent:
4371537, Feb 1, 1983
Filed:
Aug 13, 1981
Appl. No.:
6/292467
Inventors:
Lowell D. Markley - Midland MI
Yulan C. Tong - Walnut Creek CA
Steven G. Wood - Orem UT
Assignee:
The Dow Chemical Company - Midland MI
International Classification:
A61K 3144, C07D21263
US Classification:
424263
Abstract:
Sulfur-substituted phenoxypyridines having antiviral activity are disclosed. Methods of using the sulfur-substituted phenoxypyridines to employ their antiviral activity are also disclosed as well as pharmaceutically-acceptable compositions thereof.